UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH

Breast (Edinburgh), 2017-08, Vol.34, p.65-72

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathologist’s assistant (PathA) and his/her role in the surgical pathology department: a systematic review and a narrative synthesis

Virchows Archiv : an international journal of pathology, 2018-06, Vol.472 (6), p.1041-1054

2018

Link zum Volltext

Verfügbarkeit prüfen

Hyperthyroidism and pulmonary hypertension

Respiratory medicine, 2002-04, Vol.96 (4), p.215-220

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of oxytocin on nitric oxide activity controlling gonadotropin secretion in humans

European journal of clinical investigation, 2003-05, Vol.33 (5), p.402-405

2003

Link zum Volltext

Verfügbarkeit prüfen

Ductal Adenocarcinoma of the Pancreas

Surgical pathology clinics, 2011-06, Vol.4 (2), p.487-521

2011

Link zum Volltext

Verfügbarkeit prüfen

Comments, opinions, and brief case reports: desmopressin test in occult eutopic corticotropin microadenoma

Archives of internal medicine (1960), 2002-04, Vol.162 (7), p.840

2002

Link zum Volltext

Verfügbarkeit prüfen

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.21-27

2018

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of Genome Editing Mutations in Cereal Crops

Trends in plant science, 2017-01, Vol.22 (1), p.38-52

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

Breast (Edinburgh), 2022-10, Vol.65, p.145-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Patterns of CRISPR/Cas9 activity in plants, animals and microbes

Plant biotechnology journal, 2016-12, Vol.14 (12), p.2203-2216

2016

Link zum Volltext

Verfügbarkeit prüfen

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations

Lung cancer (Amsterdam, Netherlands), 2011-02, Vol.71 (2), p.241-243

2011

Link zum Volltext

Verfügbarkeit prüfen

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

British journal of cancer, 2013-04, Vol.108 (8), p.1695-1703

2013

Link zum Volltext

Verfügbarkeit prüfen

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents

ESMO open, 2024-07, Vol.9 (7), p.103629, Article 103629

2024

Link zum Volltext

Verfügbarkeit prüfen

145P High-risk breast cancer patients with RAD51-low tumors are characterized by good prognosis

Annals of oncology, 2021-09, Vol.32, p.S423-S424

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications

American journal of clinical pathology, 2012-11, Vol.138 (5), p.697-702

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy

The pharmacogenomics journal, 2014-02, Vol.14 (1), p.14-19

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-14-05

2019

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome

Annals of oncology, 2015-10, Vol.26, p.vi137

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.915-920

2006

Link zum Volltext

Verfügbarkeit prüfen

FDG-PET/CT as a predictor of pathological complete response (pCR) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NAC): a single center retrospective study

Annals of oncology, 2015-10, Vol.26, p.vi9

2015

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing

Applied immunohistochemistry & molecular morphology, 2012-07, Vol.20 (4), p.356

2012

Link zum Volltext

Verfügbarkeit prüfen

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Breast (Edinburgh), 2007-06, Vol.16 (3), p.280-292

2007

Link zum Volltext

Verfügbarkeit prüfen

Brca Status, Molecular Profile and Clinical Variables in Primary Bilateral Breast Cancers: A Population-Based Cancer Registry Study

Annals of oncology, 2012-09, Vol.23, p.ix175-ix176

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Female
(13)
Middle Aged
(12)
Adult
(10)
Male
(10)
Biological And Medical Sciences
(9)
Oncology
(9)
Aged
(8)
Medical Sciences
(8)
Breast Cancer
(5)
Mutation - Genetics
(5)
Tumors
(5)
Breast Neoplasms - Genetics
(4)
Immunohistochemistry
(4)
Mutation
(4)
Pathology
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH

Pathologist’s assistant (PathA) and his/her role in the surgical pathology department: a systematic review and a narrative synthesis

Hyperthyroidism and pulmonary hypertension

Effect of oxytocin on nitric oxide activity controlling gonadotropin secretion in humans

Ductal Adenocarcinoma of the Pancreas

Comments, opinions, and brief case reports: desmopressin test in occult eutopic corticotropin microadenoma

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

Characteristics of Genome Editing Mutations in Cereal Crops

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

Patterns of CRISPR/Cas9 activity in plants, animals and microbes

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents

145P High-risk breast cancer patients with RAD51-low tumors are characterized by good prognosis

Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Clinicopathological Characteristics and Molecular Analyses of Multifocal Intraductal Papillary Mucinous Neoplasms of the Pancreas

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy

Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice

FDG-PET/CT as a predictor of pathological complete response (pCR) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NAC): a single center retrospective study

EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Brca Status, Molecular Profile and Clinical Variables in Primary Bilateral Breast Cancers: A Population-Based Cancer Registry Study

Suchergebnisse filtern